Liying Ma
Tianjin University of Technology(CN)Tianjin University(CN)Inner Mongolia People's Hospital(CN)National Institutes for Food and Drug Control(CN)
Publications by Year
Research Areas
HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research, Immune Cell Function and Interaction
Most-Cited Works
- → Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment(2012)315 cited
- → CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo(2017)241 cited
- → Identification of N-phenyl-N′-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4(2005)215 cited
- → Electrospun Nanofibrous Membranes: A Novel Solid Substrate for Microfluidic Immunoassays for HIV(2008)160 cited
- → Morphologically Virus‐Like Fullerenol Nanoparticles Act as the Dual‐Functional Nanoadjuvant for HIV‐1 Vaccine(2013)137 cited
- → Point-of-Care Multiplexed Assays of Nucleic Acids Using Microcapillary-based Loop-Mediated Isothermal Amplification(2014)107 cited